Gene-drug interactions (data source: DGIdb)
Gene Name Entrez ID Drug Name Chembl ID Interaction Types Sources publications
EPO 2056 CETUXIMAB CHEMBL1201577 NCI 2016633
EPO 2056 GONADOTROPIN, CHORIONIC CHEMBL1201509 NCI 11585432
EPO 2056 ARSENIC TRIOXIDE CHEMBL1200978 NCI 15690072
EPO 2056 MYCOPHENOLATE MOFETIL CHEMBL1456 NCI 11750393
EPO 2056 OXYMETHOLONE CHEMBL1200585 NCI 1009362

Variant-drug associations (data source: PharmGKB)
Gene Name Variant Alleles Chemical Phenotype Category Significance Notes Sentence Publications Annotation ID
EPO rs1617640 AA bevacizumab efficacy no No significant difference in genotype frequencies was seen between patients classified as non-responders, and those classified as responders or partial responders. Responder status was determined by optical coherence tomography; please refer to the paper directly for definitions of responder, partial responder, and non-responder. Please note that alleles have been complemented to the plus chromosomal strand. Genotype AA is not associated with response to bevacizumab in people with Macular Degeneration as compared to genotypes AC + CC. 23584701 1184166145